Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database

Archive ouverte

Pageot, Cécile | Bezin, Julien | Smith, Andy | Arnaud, Mickael | Salvo, Francesco | Haramburu, Françoise | Pariente, Antoine | Bégaud, Bernard

Edité par CCSD ; Springer Verlag -

International audience. The objective of this study was to analyse the changes in the reporting of adverse events (AEs) for therapeutic alternatives after the withdrawal of three medicines (dextropropoxyphene, pioglitazone and tetrazepam) from the market for safety reasons.

Consulter en ligne

Suggestions

Du même auteur

Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients

Archive ouverte | Pariente, Antoine | CCSD

International audience

Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study

Archive ouverte | Letinier, Louis | CCSD

International audience. Introduction: Drug interactions could account for 1% of hospitalizations in the general population and 2-5% of hospital admissions in the elderly. However, few data are available on the drugs...

Risk of bradyarrhythmia related to ticagrelor: a systematic review and meta-analysis. : Pharmacol Res

Archive ouverte | Pujade, Iris | CCSD

International audience. ContextTicagrelor was related to bradycardia in DISPERSE-II trial. This risk has been integrated into the European risk-management plan, and its use is warned in at-risk patients. Nevertheles...

Chargement des enrichissements...